Ideaya partners with Gilead; Lilly extends offer for Point; Theseus lets go of CEO, CMO
Ideaya and Gilead will study a potential combo in bladder cancer. The South San Francisco-based company announced Monday that it plans …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
